Introduction: With the increasing use of immune checkpoint inhibitors. ocular adverse events have gained attention. We describe a case of atypical keratitis presumably induced by atezolizumab. a programmed cell death ligand 1 inhibitor. https://fvdoez9a6prw.dsiblogger.com/67920908/organization-of-accountance-in-health-and-fitness-institutions